Carlos Parra-Herran MD

2.1K posts

Carlos Parra-Herran MD

Carlos Parra-Herran MD

@CPHpath

No longer using this site. Find me on BlueSky @CPHpath.bsky.social

Boston, MA Katılım Haziran 2017
1.3K Takip Edilen2.7K Takipçiler
Carlos Parra-Herran MD retweetledi
Dr Ahmad Rehan Khan
Dr Ahmad Rehan Khan@AhmadRehanKhan·
𝗜𝗠𝗚𝘀 𝗔𝗥𝗘𝗡'𝗧 𝗦𝘁𝗲𝗮𝗹𝗶𝗻𝗴 𝗨𝗦 𝗝𝗼𝗯𝘀: Amid the noise and baseless accusations that IMGs are “stealing” residency spots, I’ve put together a comprehensive, data-driven breakdown that cuts through the misinformation. This article debunks these claims with facts, context, and real ground realities, and clearly explains how residency positions are actually distributed between U.S. graduates and IMGs. Because this conversation deserves evidence, not assumptions. Let’s kill this myth once and for all 👇 ❌ IMGs are NOT “stealing” residency spots: 📊 Match 2026 Reality: 🔹 Total U.S. MD + DO applicants: 33,070 🔹Total residency positions: 44,344 ➡️ Surplus positions: +11,274 🚨 The Gap Nobody Talks About: Even if EVERY single U.S. graduate matched… There would STILL be 11,274 unfilled positions 📉 Workforce Crisis: Projected physician shortage: 86,000 by 2036 (American Medical Association) 🤔 The Real Question: Who fills those 11,274 positions? 💡 The Truth: Without IMGs: ❌ Positions go unfilled ❌ Hospitals, especially community and rural, struggle to function ❌ Patient care suffers 🩺 Bottom Line: IMGs don’t take spots They fill the gaps that keep the system running ANOTHER ASPECT: In core specialties like Internal Medicine, Family Medicine, Pediatrics, Psychiatry, and Neurology, virtually no U.S. MD or DO applicant who is willing to train in these fields remains unmatched after SOAP. These are not the arenas where U.S. graduates are being displaced. The unmatched issue arises when applicants, understandably, aim for ultra competitive specialties like Orthopedic Surgery, Plastic Surgery, Neurosurgery, and Dermatology. In those fields, they are competing against other highly accomplished U.S. graduates and a very small group of IMGs who are not average by any standard, but truly exceptional. The IMGs who break into these specialties are rare, and their profiles speak for themselves, extremely high scores, dozens of publications, hundreds of citations, and often postdoctoral research fellowships, frequently at the very institutions where they eventually match. They have already worked alongside senior faculty, proven their competence, and demonstrated their work ethic over time. When programs rank them highly, it is not favoritism, it is informed judgment based on direct experience. To suggest that institutions like Harvard University, Yale University, Stanford University, Columbia University would deliberately choose less competitive candidates over stronger ones simply because of citizenship is not just incorrect, it fundamentally misunderstands how merit based selection works in academic medicine. These institutions built their reputation on excellence, not compromise. And finally, why are IMGs coming to the United States in the first place? Because the U.S. has a large, widely distributed population, a worsening physician shortage, and a healthcare system that actively needs them. For decades, the U.S. projected itself as a land of opportunity, attracting talent from across the world. Now that highly qualified physicians are pursuing that opportunity through a legal, merit based system, some have a problem with it. At that point, the issue is no longer about residency positions or qualifications. It is about bias, not facts. #Match2026 #MedTwitter #MedEd
Dr Ahmad Rehan Khan tweet mediaDr Ahmad Rehan Khan tweet mediaDr Ahmad Rehan Khan tweet media
Goshen, NY 🇺🇸 English
13
15
80
4.7K
Carlos Parra-Herran MD retweetledi
James Blunt
James Blunt@JBlunt1018·
When you zoom out: ~40,000 residency spots ~28,000 U.S. grads That leaves ~12,000 seats with NO American doctors to fill them. So who exactly is being “replaced”?
James Blunt tweet media
English
107
155
1.3K
174.5K
Carlos Parra-Herran MD retweetledi
Mass General Brigham Pathology
Mass General Brigham Pathology@MGBpathology·
Introducing our new MGB Pathology PGY-1s!! We’re so excited for you to join us and can’t wait to welcome you to the path family 🎉🔬🧫🤍
Mass General Brigham Pathology tweet media
English
0
20
95
12.7K
Carlos Parra-Herran MD retweetledi
Mass General Brigham Pathology
Mass General Brigham Pathology@MGBpathology·
We couldn’t be more thrilled to introduce this stellar new class of 19 (yes, 19!) PGY1s joining the Mass General Brigham pathology family! 🥳 Welcome to the team — we can’t wait to have you on board and see you thrive! 🧬🔬💫
Mass General Brigham Pathology tweet media
English
3
18
158
26.6K
Carlos Parra-Herran MD retweetledi
LAPF Patología
LAPF Patología@LatinAmericanPF·
Join LAPF during #USCAP2025 in Boston for a variety of social and educational activities Unete a las actividades sociales y educativas que LAPF tiene durante la reunion anual de @TheUSCAP Para aplicar al galardon LAPF al mejor abstract, envianos un correo antes de 03/20 🏆📰
LAPF Patología tweet mediaLAPF Patología tweet media
Español
0
6
15
1.6K
Ruth Estrada
Ruth Estrada@amigaRUTH·
Un gran gusto tenerte por acá!!! Gran evento!!! No se lo pueden perder! @CPHpath
Ruth Estrada tweet media
Español
1
3
6
494
Carlos Parra-Herran MD retweetledi
MGH Pathology
MGH Pathology@MGHPathology·
We are officially transitioning to our joint department account @mgbpathology. The MGH-specific page will still exist for reference, but please see our new page for updates and interactions! 🙂
MGH Pathology tweet media
English
1
3
13
3.7K
Carlos Parra-Herran MD retweetledi
Brigham and Women's Pathology
We are officially transitioning to our joint department account @mgbpathology. The BWH-specific page will still exist for reference, but please see our new page for updates and interactions! 🙂
Brigham and Women's Pathology tweet media
English
0
3
15
2.3K
Carlos Parra-Herran MD retweetledi
LAPF Patología
LAPF Patología@LatinAmericanPF·
Estamos en vivo con la última clase del programa del #cursovirtualLAPF, Patología Gastrointestinal con el Dr. Iván González. No se olviden de la clase "bonus" del viernes 29 de noviembre con el Dr. Mario Murguía Pérez @Allende_DS @Andres_M_Acosta
LAPF Patología tweet media
Español
0
2
7
510
Carlos Parra-Herran MD retweetledi
LAPF Patología
LAPF Patología@LatinAmericanPF·
⚠️ATENCIÓN #cursovirtualLAPF ✅clase bonus: Inmunohistoquímica "Presentación de casos". Dr. Mario Murguía Pérez 🇲🇽 🗓️ viernes 29 de noviembre, 8 pm (Arg/Uru, GMT-3) @Allende_DS @Andres_M_Acosta
LAPF Patología tweet media
Español
0
3
5
842
Carlos Parra-Herran MD retweetledi
MGH Pathology
MGH Pathology@MGHPathology·
The Tear Downs aptly tore it down last night 🤘🎸 Dr. Hornick, featured on the keyboard, is our director of surgical pathology and immunohistochemistry at the Brigham, but more importantly he’s a rockstar @JLHornick
MGH Pathology tweet mediaMGH Pathology tweet media
English
2
4
28
1.6K
Carlos Parra-Herran MD retweetledi
Rhonda Yantiss
Rhonda Yantiss@RhondaYantiss·
Thank you to the Abstract Review Board and Abstract Assignment Committee at @TheUSCAP for the timely dispositions of abstracts for 2025. Every year is better and better!
English
3
5
46
3.7K